Efficacy of essential measures to be performed in ICU on patients’ outcome in Japan and Korea MSICUs: Prospective data registry and retrospective analysis
- Conditions
- Not Applicable
- Registration Number
- KCT0001549
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 600
1.=20 years old
2.Patients who expected to still be ICU the day after tomorrow of randomization
and at least stay for 72 hours
Patients will be excluded from the study if they meet ANY of the following criteria:
1. Pregnancy
2. Acute brain injury defined as acute traumatic brain injury, subarachnoid haemorrhage, acute ischaemic stroke, acute intracerebral haemorrhage, acute intracranial infection or cardiac arrest.
3. Continuous medication of anticoagulation such as warfarin before ICU admission for any reason
(except for anti-platelet agents)
4. Patients who need just within 24 hour monitoring after procedure or operation.
5. Patients who expected require ECMO within 24 hours after randomization.
6. Patients who are judged as or expected as brain death.
7. Terminal cancer patients whose life expectancy is less than 1 month
8. Patients who refuse to participate in study
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Daily rate of implementation of essential measures
- Secondary Outcome Measures
Name Time Method rate of complications in IC